Pfizer
PFE
PFE
2,853 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q1 according to their latest regulatory filings, with 188 funds opening new positions, 1,214 increasing their positions, 1,240 reducing their positions, and 214 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,853
Holders Change
-61
Holders Change %
-2.09%
% of All Funds
41.37%
Holding in Top 10
31
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-20.51%
% of All Funds
0.45%
New
188
Increased
1,214
Reduced
1,240
Closed
214
Calls
$2.19B
Puts
$3.82B
Net Calls
-$1.62B
Net Calls Change
-$611M
Top Buyers
| 1 |
1
Charles Schwab
San Francisco,
California
|
$3.37B |
| 2 |
2
Two Sigma Advisers
New York
|
$376M |
| 3 |
3
Barclays
London,
United Kingdom
|
$598M |
| 4 |
4
D.E. Shaw & Co
New York
|
$674M |
| 5 |
5
Two Sigma Investments
New York
|
$234M |
